T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 09/30/2014
Domestic Stock 88.9%
Foreign Stock 7.5%
Cash 3.4%
Convertibles 0.3%
Foreign Bonds 0.0%
Preferreds 0.0%
Options -0.1%
Volatility and Other Measures
as of 11/30/2014
Beta 1.04
Standard Deviation 13.56
Price/Earnings Ratio (Domestic) 21.5
Earnings Growth Rate (Domestic) 14.3
Turnover Rate 41.7
Median Market
$30,215.06 Million
10 Largest Holdings
Represents 34.36 % of Total Net Assets
View Holdings as of:
Actavis plc
Alexion Pharmaceuticals
Allergan Inc/United States
Gilead Sciences
UnitedHealth Group
Valeant Pharmaceuticals International
As of 09/30/2014 the Health Sciences Fund had a total of 154 holdings.
Sector Diversification
as of 11/30/2014
% of Total Net Assets
Biotechnology 31.0%
Services 24.1%
Pharmaceuticals 23.6%
Products & Devices 11.9%
Life Sciences 3.7%
Miscellaneous 2.7%
See Glossary for additional details on all data elements.